Calcipotriol & Betamethasone Dipropionate Gel is a topical medication used for the treatment of plaque psoriasis in adult patients 18 years or older. It combines the pharmacological effects of calcipotriol and betamethasone dipropionate to reduce inflammation and treat the scaling associated with psoriasis.

Indication:

• Calcipotriol & Betamethasone Dipropionate Gel is indicated for the topical treatment of stable plaque psoriasis vulgaris in adults 18 years of age and above.

Dosage:

• The recommended treatment period is 4 weeks, and after this period, repeated treatment with the two-compound product can be initiated under medical supervision according to the new product label.
• The systemic exposure to calcipotriol and betamethasone dipropionate from topically applied Calcipotriol betamethasone 50 micrograms/g 0.5 mg/g combination gel is comparable to Calcipotriol betamethasone 50 micrograms/g 0.5 mg/g combination ointment in rats and minipigs.
• The efficacy of once daily use of Calcipotriol betamethasone 50 micrograms/g 0.5 mg/g combination gel was investigated in two randomized, double-blind, 8-week clinical studies including a total of more than 2,900 patients with scalp psoriasis of at least mild severity.

Please note that the information provided here is based on the search results and should not replace the advice of a healthcare professional. Always consult with your doctor or pharmacist for personalized dosage instructions and recommendations.